Taysha Gene Therapies
TSHA
TSHA
46 hedge funds and large institutions have $358M invested in Taysha Gene Therapies in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less capital invested
Capital invested by funds: $475M → $358M (-$117M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
46
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.49M | |
| 2 | +$3.63M | |
| 3 | +$913K | |
| 4 |
BlackRock
New York
|
+$638K |
| 5 |
DC
Davenport & Co
Richmond,
Virginia
|
+$409K |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$6.63M | |
| 3 | -$1.94M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$949K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$845K |